Wikileaks...more light, less clarity

With the possibility of getting a glimpse of some juicy insights into the machinations that take place in the corridors of power across the globe, it is hardly surprising that the Wikileaks publication of intra- and intergovernmental communications attracted a lot of media attention. Indeed, our coverage of what was being said in diplomatic channels about the dispute between Pfizer and the Nigerian government over a 1996 clinical trial in which 11 children died, was one of the most avidly read items on the Scrip website in the past week.